Increasing competition and decreasing reimbursement for services provided are driving healthcare organizations to seek innovative value-based, patient-safety focused solutions. Hospitals and ...

On June 1, 2019, the United States Pharmacopeia (“USP”) published the final revisions to its pharmaceutical sterile compounding standards (“chapter <797>”). Chapter <797> sets forth standards for the ...

The global non-sterile compounding pharmacy market size is calculated at USD 6.41 billion in 2025 and is expected to reach ...

Central Pharmacy IV Compounding Service creates a safer, more accurate and cost-effective IV pharmacy Nearly one out of ten IVs are not prepared within guidelines1 using manual processes and ...

The Tennessee Pharmacy Board has approved a Texas pharmacy to issue sterile compounded drugs in the state even though the company says it has suspended the production of sterile drugs while its ...

Thirteen percent of pharmacists and pharmacy technicians reported that contamination of high-risk compounded sterile products occurred in their facility in the past year, according to a survey by the ...

March 11 (Reuters) - Specialty Compounding Llc reached a settlement with the U.S. Food and Drug Administration on Wednesday, barring the company from producing and selling sterile drugs until it ...

The FDA issued a formal request to AmEx Pharmacy to recall all of its compounded drug products intended to be sterile after the company didn’t take any corrective actions following an inspection that ...

Lowlite Investments Inc, doing business as Olympia Pharmacy in Orlando, Florida, has initiated a voluntary recall of all unexpired sterile drug products compounded by the pharmacy because of a lack of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A federal judge ordered JMA Partners Inc.